Almost immediately after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) virus emerged, it was evident that people with chronic diseases, including diabetes, were …
BN Harapan, T Harapan, L Theodora… - Journal of Epidemiology …, 2023 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to countries worldwide, including Indonesia. With its unique archipelagic …
Cytokine release syndrome (CRS) due to severe acute respiratory coronavirus-2 (SARS- CoV-2) infection leads to life-threatening pneumonia which has been associated with …
FA Ambrosio, G Costa, I Romeo… - Journal of Chemical …, 2023 - ACS Publications
The SARS-CoV-2 main protease (Mpro) is a crucial enzyme for viral replication and has been considered an attractive drug target for the treatment of COVID-19. In this study, virtual …
There is an urgent need for individuals with mild to moderate COVID-19 pneumonia to learn and apply the recommended interventions for pulmonary rehabilitation. In the health …
A complex network of processes inside the human immune system provides resistance against a wide range of pathologies. These defenses form an innate and adaptive immunity …
Monoclonal antibody (mAb) therapy is one of the most promising immunotherapies that have shown the potential to prevent or neutralize the effects of COVID-19 in patients at very early …
A Libra, N Ciancio, G Sambataro, E Sciacca… - Viruses, 2023 - mdpi.com
Remdesivir is one of the most attractive options for patients with hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). The aim of our study was to evaluate …
Abstract The Coronavirus Disease-2019 (COVID-19) pandemic urges researching possibilities for prevention and management of the effects of the virus. Carotenoids are …